![PDF) Real-World Experience Using the IUB Ballerine MIDI Copper IUD: A Multicenter, Multinational Observational Study PDF) Real-World Experience Using the IUB Ballerine MIDI Copper IUD: A Multicenter, Multinational Observational Study](https://i1.rgstatic.net/publication/346855507_Real-World_Experience_Using_the_IUB_Ballerine_MIDI_Copper_IUD_A_Multicenter_Multinational_Observational_Study/links/5fd1b430a6fdcc697bf2ae00/largepreview.png)
PDF) Real-World Experience Using the IUB Ballerine MIDI Copper IUD: A Multicenter, Multinational Observational Study
![FemTech startup OCON Healthcare announces FDA acceptance of IND Application for its flagship product IUB™ Ballerine® and distribution agreements for Canada and Mexico boosting sales by $9.3 million FemTech startup OCON Healthcare announces FDA acceptance of IND Application for its flagship product IUB™ Ballerine® and distribution agreements for Canada and Mexico boosting sales by $9.3 million](https://www.startuphub.ai/wp-content/uploads/indeni-acquired-by-bluecat-networks-230x230.jpg)
FemTech startup OCON Healthcare announces FDA acceptance of IND Application for its flagship product IUB™ Ballerine® and distribution agreements for Canada and Mexico boosting sales by $9.3 million
![Rhia Ventures Invests in OCON Healthcare's Ballerine®, the first ever 3D spherical copper intrauterine contraceptive with a superior safety profile, a breakthrough in women's hormone-free birth control options Rhia Ventures Invests in OCON Healthcare's Ballerine®, the first ever 3D spherical copper intrauterine contraceptive with a superior safety profile, a breakthrough in women's hormone-free birth control options](https://mma.prnewswire.com/media/1388568/Rhia_Ventures_OCON_Healthcare_Ballerine.jpg?p=facebook)
Rhia Ventures Invests in OCON Healthcare's Ballerine®, the first ever 3D spherical copper intrauterine contraceptive with a superior safety profile, a breakthrough in women's hormone-free birth control options
Full article: Real-world experience with the IUB Ballerine MIDI copper IUD: an observational study in the French-speaking region of Switzerland
![FemTech startup OCON Healthcare announces FDA acceptance of IND Application for its flagship product IUB™ Ballerine® and distribution agreements for Canada and Mexico boosting sales by $9.3 million FemTech startup OCON Healthcare announces FDA acceptance of IND Application for its flagship product IUB™ Ballerine® and distribution agreements for Canada and Mexico boosting sales by $9.3 million](https://www.startuphub.ai/wp-content/uploads/dig-security-raises-strategic-from-samsung-ventures-230x230.jpg)